UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 31, 2016
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to .
Commission File Number: 001-36743
Apple Inc.
(Exact name of Registrant as specified in its charter)
California
94-2404110
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer Identification No.)
1 Infinite Loop
Cupertino, California
95014
(Address of principal executive offices)
(Zip Code)
(408) 996-1010
(Registrant s telephone number, including area code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes No
Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).
Yes No
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
(Do not check if a smaller reporting company)
Smaller reporting company
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes No
5,246,540,000 shares of common stock, par value $0.00001 per share, issued and outstanding as of January 20, 2017
Apple Inc.
Form 10-Q
For the Fiscal Quarter Ended December 31, 2016
TABLE OF CONTENTS
Page
Part I
Item 1.
Financial Statements
Item 2.
Management s Discussion and Analysis of Financial Condition and Results of Operations
22
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
32
Item 4.
Controls and Procedures
32
Part II
Item 1.
Legal Proceedings
33
Item 1A.
Risk Factors
33
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
43
Item 3.
Defaults Upon Senior Securities
43
Item 4.
Mine Safety Disclosures
43
Item 5.
Other Information
43
Item 6.
Exhibits
44
PART I FINANCIAL INFORMATION
Item 1.
Financial Statements
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(In millions, except number of shares which are reflected in thousands and per share amounts)
Three Months Ended
December 31,
2016
December 26,
2015
Net sales
78,351
75,872
Cost of sales
48,175
45,449
Gross margin
30,176
30,423
Operating expenses:
Research and development
2,871
2,404
Selling, general and administrative
3,946
3,848
Total operating expenses
6,817
6,252
Operating income
23,359
24,171
Other income/(expense), net
821
402
Income before provision for income taxes
24,180
24,573
Provision for income taxes
6,289
6,212
Net income
17,891
18,361
Earnings per share:
Basic
3.38
3.30
Diluted
3.36
3.28
Shares used in computing earnings per share:
Basic
5,298,661
5,558,930
Diluted
5,327,995
5,594,127
Cash dividends declared per share
0.57
0.52
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(In millions)
Three Months Ended
December 31,
2016
December 26,
2015
Net income
17,891
18,361
Other comprehensive income/(loss):
Change in foreign currency translation, net of tax effects of $76 and $19, respectively
(375
(102
Change in unrealized gains/losses on derivative instruments:
Change in fair value of derivatives, net of tax benefit/(expense) of $(228) and $(38), respectively
1,468
287
Adjustment for net (gains)/losses realized and included in net income, net of tax expense/(benefit) of $(211) and $66, respectively
306
(445
Total change in unrealized gains/losses on derivative instruments, net of tax
1,774
(158
Change in unrealized gains/losses on marketable securities:
Change in fair value of marketable securities, net of tax benefit/(expense) of $989 and $508, respectively
(1,808
(922
Adjustment for net (gains)/losses realized and included in net income, net of tax expense/(benefit) of $(11) and $(26), respectively
20
47
Total change in unrealized gains/losses on marketable securities, net of tax
(1,788
(875
Total other comprehensive income/(loss)
(389
(1,135
Total comprehensive income
17,502
17,226
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(In millions, except number of shares which are reflected in thousands and par value)
December 31,
2016
September 24,
2016
ASSETS:
Current assets:
Cash and cash equivalents
16,371
20,484
Short-term marketable securities
44,081
46,671
Accounts receivable, less an allowance of $53 in each period
14,057
15,754
Inventories
2,712
2,132
Vendor non-trade receivables
13,920
13,545
Other current assets
12,191
8,283
Total current assets
103,332
106,869
Long-term marketable securities
185,638
170,430
Property, plant and equipment, net
26,510
27,010
Goodwill
5,423
5,414
Acquired intangible assets, net
2,848
3,206
Other non-current assets
7,390
8,757
Total assets
331,141
321,686
LIABILITIES AND SHAREHOLDERS EQUITY:
Current liabilities:
Accounts payable
38,510
37,294
Accrued expenses
23,739
22,027
Deferred revenue
7,889
8,080
Commercial paper
10,493
8,105
Current portion of long-term debt
3,499
3,500
Total current liabilities
84,130
79,006
Deferred revenue, non-current
3,163
2,930
Long-term debt
73,557
75,427
Other non-current liabilities
37,901
36,074
Total liabilities
198,751
193,437
Commitments and contingencies
Shareholders equity:
Common stock and additional paid-in capital, $0.00001 par value: 12,600,000 shares authorized; 5,255,423 and 5,336,166 shares issued and outstanding, respectively
32,144
31,251
Retained earnings
100,001
96,364
Accumulated other comprehensive income/(loss)
245
634
Total shareholders equity
132,390
128,249
Total liabilities and shareholders equity
331,141
321,686
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(In millions)
Three Months Ended
December 31,
2016
December 26,
2015
Cash and cash equivalents, beginning of the period
20,484
21,120
Operating activities:
Net income
17,891
18,361
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
2,987
2,954
Share-based compensation expense
1,256
1,078
Deferred income tax expense
1,452
1,592
Other
(274
110
Changes in operating assets and liabilities:
Accounts receivable, net
1,697
3,896
Inventories
(580
(102
Vendor non-trade receivables
(375
1,826
Other current and non-current assets
(1,446
(1,058
Accounts payable
2,460
(852
Deferred revenue
42
(29
Other current and non-current liabilities
1,946
(313
Cash generated by operating activities
27,056
27,463
Investing activities:
Purchases of marketable securities
(54,272
(47,836
Proceeds from maturities of marketable securities
6,525
3,514
Proceeds from sales of marketable securities
32,166
28,262
Payments made in connection with business acquisitions, net
(17
(86
Payments for acquisition of property, plant and equipment
(3,334
(3,612
Payments for acquisition of intangible assets
(86
(394
Payments for strategic investments
(126
Other
(104
(172
Cash used in investing activities
(19,122
(20,450
Financing activities:
Proceeds from issuance of common stock
Excess tax benefits from equity awards
178
224
Payments for taxes related to net share settlement of equity awards
(629
(597
Payments for dividends and dividend equivalents
(3,130
(2,969
Repurchases of common stock
(10,851
(6,863
Change in commercial paper, net
2,385
(1,240
Cash used in financing activities
(12,047
(11,444
Increase/(Decrease) in cash and cash equivalents
(4,113
(4,431
Cash and cash equivalents, end of the period
16,371
16,689
Supplemental cash flow disclosure:
Cash paid for income taxes, net
3,510
3,398
Cash paid for interest
497
396
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 Summary of Significant Accounting Policies
Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs, manufactures and markets mobile communication and media devices, personal computers and portable digital music players, and sells a variety of related software, services, accessories, networking solutions and third-party digital content and applications. The Company s products and services include iPhone , iPad , Mac , iPod , Apple Watch , Apple TV , a portfolio of consumer and professional software applications, iOS, macOS , watchOS and tvOS operating systems, iCloud , Apple Pay and a variety of accessory, service and support offerings. The Company sells and delivers digital content and applications through the iTunes Store , App Store , Mac App Store, TV App Store, iBooks Store and Apple Music (collectively Digital Content and Services ). The Company sells its products worldwide through its retail stores, online stores and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the Company sells a variety of third-party Apple-compatible products, including application software and various accessories through its retail and online stores. The Company sells to consumers, small and mid-sized businesses and education, enterprise and government customers.
Basis of Presentation and Preparation
The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. In the opinion of the Company s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated financial statements have been reclassified to conform to the current period s presentation. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company's annual consolidated financial statements and the notes thereto included in its Annual Report on Form 10-K for the fiscal year ended September 24, 2016 (the 2016 Form 10-K ).
The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. The Company s fiscal year 2017 will include 53 weeks and ends on September 30, 2017 and its fiscal year 2016 included 52 weeks and ended on September 24, 2016. A 14th week has been included in the first quarter of 2017, as is done every five or six years, to realign fiscal quarters with calendar quarters. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
Earnings Per Share
Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased by employees under the Company s employee stock purchase plan, unvested restricted stock and unvested restricted stock units ( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company s common stock can result in a greater dilutive effect from potentially dilutive securities.
The following table shows the computation of basic and diluted earnings per share for the three months ended December 31, 2016 and December 26, 2015 (net income in millions and shares in thousands):
Three Months Ended
December 31,
2016
December 26,
2015
Numerator:
Net income
17,891
18,361
Denominator:
Weighted-average shares outstanding
5,298,661
5,558,930
Effect of dilutive securities
29,334
35,197
Weighted-average diluted shares
5,327,995
5,594,127
Basic earnings per share
3.38
3.30
Diluted earnings per share
3.36
3.28
Potentially dilutive securities whose effect would have been antidilutive are excluded from the computation of diluted earnings per share.
Note 2 Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company s cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of December 31, 2016 and September 24, 2016 (in millions):
December 31, 2016
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
9,359
9,359
9,359
Level 1 (1):
Money market funds
4,640
4,640
4,640
Mutual funds
1,004
(137
867
867
Subtotal
5,644
(137
5,507
4,640
867
Level 2 (2):
U.S. Treasury securities
48,431
47
(333
48,145
1,022
13,074
34,049
U.S. agency securities
4,284
(10
4,278
404
1,999
1,875
Non-U.S. government securities
7,574
79
(136
7,517
408
7,109
Certificates of deposit and time deposits
5,893
5,893
334
4,089
1,470
Commercial paper
3,750
3,750
536
3,214
Corporate securities
140,697
469
(737
140,429
76
20,283
120,070
Municipal securities
955
(9
946
111
835
Mortgage- and asset-backed securities
20,486
23
(243
20,266
36
20,230
Subtotal
232,070
622
(1,468
231,224
2,372
43,214
185,638
Total
247,073
622
(1,605
246,090
16,371
44,081
185,638
September 24, 2016
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
8,601
8,601
8,601
Level 1 (1):
Money market funds
3,666
3,666
3,666
Mutual funds
1,407
(146
1,261
1,261
Subtotal
5,073
(146
4,927
3,666
1,261
Level 2 (2):
U.S. Treasury securities
41,697
319
(4
42,012
1,527
13,492
26,993
U.S. agency securities
7,543
16
7,559
2,762
2,441
2,356
Non-U.S. government securities
7,609
259
(27
7,841
110
818
6,913
Certificates of deposit and time deposits
6,598
6,598
1,108
3,897
1,593
Commercial paper
7,433
7,433
2,468
4,965
Corporate securities
131,166
1,409
(206
132,369
242
19,599
112,528
Municipal securities
956
961
167
794
Mortgage- and asset-backed securities
19,134
178
(28
19,284
31
19,253
Subtotal
222,136
2,186
(265
224,057
8,217
45,410
170,430
Total
235,810
2,186
(411
237,585
20,484
46,671
170,430
(1)
Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities.
(2)
Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The maturities of the Company s long-term marketable securities generally range from one to five years.
The Company considers the declines in market value of its marketable securities investment portfolio to be temporary in nature. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy generally requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates and the Company s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment s cost basis. As of December 31, 2016, the Company does not consider any of its investments to be other-than-temporarily impaired.
Derivative Financial Instruments
The Company may use derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future cash flows, on net investments in certain foreign subsidiaries and on certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates.
To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company s subsidiaries whose functional currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.
To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. In addition, the Company may use non-derivative financial instruments, such as its foreign currency-denominated debt, as economic hedges of its net investments in certain foreign subsidiaries. In both of these cases, the Company designates these instruments as net investment hedges.
The Company may also enter into non-designated foreign currency contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies.
The Company may enter into interest rate swaps, options, or other instruments to manage interest rate risk. These instruments may offset a portion of changes in income or expense, or changes in fair value of the Company s term debt or investments. The Company designates these instruments as either cash flow or fair value hedges. The Company s hedged interest rate transactions as of December 31, 2016 are expected to be recognized within 10 years.
Cash Flow Hedges
The effective portions of cash flow hedges are recorded in accumulated other comprehensive income ( AOCI ) until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in other income/(expense), net in the same period as the related income or expense is recognized. The ineffective portions and amounts excluded from the effectiveness testing of cash flow hedges are recognized in other income/(expense), net.
Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified immediately into other income/(expense), net. Any subsequent changes in fair value of such derivative instruments are reflected in other income/(expense), net unless they are re-designated as hedges of other transactions.
Net Investment Hedges
The effective portions of net investment hedges are recorded in other comprehensive income ( OCI ) as a part of the cumulative translation adjustment. The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges are recognized in other income/(expense), net.
Fair Value Hedges
Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value of the underlying hedged item.
Non-Designated Derivatives
Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. As a result, during the three months ended December 31, 2016, the Company recognized gains in net sales, cost of sales and other income/(expense), net of $273 million, $332 million and $508 million, respectively.
The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company s accounting treatment for these derivative instruments is based on its hedge designation. The following tables show the Company s derivative instruments at gross fair value as of December 31, 2016 and September 24, 2016 (in millions):
December 31, 2016
Fair Value of
Derivatives Designated
as Hedge Instruments
Fair Value of
Derivatives Not Designated
as Hedge Instruments
Total
Fair Value
Derivative assets (1):
Foreign exchange contracts
1,453
1,104
2,557
Interest rate contracts
186
186
Derivative liabilities (2):
Foreign exchange contracts
977
536
1,513
Interest rate contracts
331
331
10
September 24, 2016
Fair Value of
Derivatives Designated
as Hedge Instruments
Fair Value of
Derivatives Not Designated
as Hedge Instruments
Total
Fair Value
Derivative assets (1):
Foreign exchange contracts
518
153
671
Interest rate contracts
728
728
Derivative liabilities (2):
Foreign exchange contracts
935
134
1,069
Interest rate contracts
(1)
The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed Consolidated Balance Sheets.
(2)
The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed Consolidated Balance Sheets.
The following table shows the pre-tax gains and losses of the Company s derivative and non-derivative instruments designated as cash flow, net investment and fair value hedges in OCI and the Condensed Consolidated Statements of Operations for the three months ended December 31, 2016 and December 26, 2015 (in millions):
Three Months Ended
December 31,
2016
December 26,
2015
Gains/(Losses) recognized in OCI effective portion:
Cash flow hedges:
Foreign exchange contracts
1,727
326
Interest rate contracts
Total
1,734
334
Net investment hedges:
Foreign exchange contracts
Foreign currency debt
122
10
Total
122
10
Gains/(Losses) reclassified from AOCI into net income effective portion:
Cash flow hedges:
Foreign exchange contracts
(511
515
Interest rate contracts
(1
(4
Total
(512
511
Gains/(Losses) on derivative instruments:
Fair value hedges:
Interest rate contracts
(872
(111
Gains/(Losses) related to hedged items:
Fair value hedges:
Interest rate contracts
872
111
11
The following table shows the notional amounts of the Company s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of December 31, 2016 and September 24, 2016 (in millions):
December 31, 2016
September 24, 2016
Notional
Amount
Credit Risk
Amount
Notional
Amount
Credit Risk
Amount
Instruments designated as accounting hedges:
Foreign exchange contracts
40,526
1,453
44,678
518
Interest rate contracts
24,500
186
24,500
728
Instruments not designated as accounting hedges:
Foreign exchange contracts
57,144
1,104
54,305
153
The notional amounts for outstanding derivative instruments provide one measure of the transaction volume outstanding and do not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts represent the Company s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency or interest rates at each respective date. The Company s exposure to credit loss and market risk will vary over time as currency and interest rates change. Although the table above reflects the notional and credit risk amounts of the Company s derivative instruments, it does not reflect the gains or losses associated with the exposures and transactions that the instruments are intended to hedge. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.